J Korean Cancer Assoc.
2000 Apr;32(2):331-338.
Prognostic Factors and Survival Analysis for Patients with Colorectal
Carcinomas
Abstract
-
PURPOSE: Colorectal carcinomas are one of the most common malignant tumors in western
countries. In Korea, it is the fourth common malignancy and the incidence has been rising
over the past 10 years. We studied respectively to analyse prognostic factors in patients
with colorectal cancer.
MATERIALS AND METHODS
893 patients with primary colorectal carcinomas who were operated
at our hospital between 1989 and 1997 were reviewed. We examined possible prognostic factors
such as, age and sex of patients, size and location of tumors, preoperative serum CEA and
CA19-9 level, modified Dukes stage, operative methods, and lymph node metastases.
RESULTS
Overall 5-year survival rate was 61.8%. The 5-year survival rates in modified Dukes
stage A, Bl, B2, Cl, C2 and D were 100%, 89.4%, 72.5%, 63.3%, 55.1% and 21.5%, respectively.
Univariate analysis showed that age, modified Dukes stage, preoperative serum CEA and CA19-9
level, and lymphatic metastases were significant factors. The size of tumor was a significant
factor in rectal carcinomas but not in colon carcinomas. In extraperitoneal rectal carcinomas,
there were no survival differences between low anterior resection and abdominoperineal
resection groups. Preoperative serum CEA level and modified Dukes' stage were significant
in multivariate analysis,
CONCLUSION
Modified Dukes stage, preoperative serum CEA were independent prognostic factors
for patients with colorectal cancer.